文献速递骨质疏松与钙磷/甲状旁腺

补充维生素D预防急性呼吸道感染:分层汇总数据的系统综述与Meta分析

Vitamin D supplementation to prevent acute respiratory infections: systematic review and meta-analysis of stratified aggregate data.
PubMed 文献 · Lancet Diabetes Endocrinol · 2025-02-21

总体效应无统计学显著性(OR 0.94,95%CI 0.88-1.00,p=0.057),预设亚组分析未发现年龄、基线维生素D状态、给药频率或剂量大小的效应修饰证据。

要点

  • 维生素D补充对急性呼吸道感染总体风险无统计学显著影响(OR 0.94,95%CI 0.88-1.00,p=0.057)。
  • 预设亚组分析未发现年龄、基线25(OH)D浓度、给药频率或剂量大小存在效应修饰。
  • 维生素D对至少发生一次严重不良事件的比例无影响(OR 0.96,95%CI 0.90-1.04)。

核心结论

  • 本更新Meta分析对维生素D补充与急性呼吸道感染风险总体效应的点估计与既往相似,但95%CI现包含1.00,表明无统计学显著保护作用。

研究设计与样本

  • 更新系统综述与Meta分析,采用随机效应模型,检索MEDLINE、EMBASE、Cochrane对照试验中心注册库、Web of Science和ClinicalTrials.gov,检索时间范围为2020年5月1日至2024年4月30日,无语言限制。
  • 纳入双盲随机对照试验,补充维生素D任意时长,以安慰剂或低剂量维生素D为对照,需经研究伦理委员会批准且急性呼吸道感染发生率前瞻性收集并预设为疗效结局。
  • 共识别6项新随机对照试验(19337名参与者),获得其中3项新试验16085名(83.2%)参与者的数据,与既往Meta分析中43项随机对照试验的48488名参与者数据合并。
  • 研究注册于PROSPERO(注册号CRD42024527191)。

主要发现

  • 任何维生素D与安慰剂比较的主要分析显示,干预对总体急性呼吸道感染风险无统计学显著影响(OR 0.94,95%CI 0.88-1.00,p=0.057;40项研究;61589名参与者;I²=26.4%)。
  • 预设亚组分析未发现年龄、基线维生素D状态、给药频率或剂量大小存在效应修饰的证据。
  • 维生素D对至少发生一次严重不良事件的参与者比例无影响(OR 0.96,95%CI 0.90-1.04;38项研究;I²=0.0%)。
  • 漏斗图显示左侧不对称(Egger检验p=0.0020)。

局限性

  • 漏斗图显示左侧不对称(Egger检验p=0.0020)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A 2021 meta-analysis of 37 randomised controlled trials (RCTs) of vitamin D supplementation for prevention of acute respiratory infections (ARIs) revealed a statistically significant protective effect of the intervention (odds ratio [OR] 0·92 [95% CI 0·86 to 0·99]). Since then, six eligible RCTs have been completed, including one large trial (n=15 804). We aimed to re-examine the link between vitamin D supplementation and prevention of ARIs. METHODS: Updated systematic review and meta-analysis of data from RCTs of vitamin D for ARI prevention using a random effects model. Subgroup analyses were done to determine whether effects of vitamin D on risk of ARI varied according to baseline 25-hydroxyvitamin D (25[OH]D) concentration, dosing regimen, or age. We searched MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials, Web of Science, and the ClinicalTrials.gov between May 1, 2020 (end-date of search of our previous meta-analysis) and April 30, 2024. No language restrictions were imposed. Double-blind RCTs supplementing vitamin D for any duration, with placebo or lower-dose vitamin D control, were eligible if approved by a Research Ethics Committee and if ARI incidence was collected prospectively and pre-specified as an efficacy outcome. Aggregate data, stratified by baseline 25(OH)D concentration and age, were obtained from study authors. The study was registered with PROSPERO (no. CRD42024527191). FINDINGS: We identified six new RCTs (19 337 participants). Data were obtained for 16 085 (83·2%) participants in three new RCTs and combined with data from 48 488 participants in 43 RCTs identified in our previous meta-analysis. For the primary comparison of any vitamin D versus placebo, the intervention did not statistically significantly affect overall ARI risk (OR 0·94 [95% CI 0·88-1·00], p=0·057; 40 studies; 61 589 participants; I2=26·4%). Pre-specified subgroup analysis did not reveal evidence of effect modification by age, baseline vitamin D status, dosing frequency, or dose size. Vitamin D did not influence the proportion of participants experiencing at least one serious adverse event (OR 0·96 [95% CI 0·90-1·04]; 38 studies; I2=0·0%). A funnel plot showed left-sided asymmetry (p=0·0020, Egger's test). INTERPRETATION: This updated meta-analysis yielded a similar point estimate for the overall effect of vitamin D supplementation on ARI risk to that obtained previously, but the 95% CI for this effect estimate now includes 1·00, indicating no statistically significant protection. FUNDING: None.

来源:Lancet Diabetes Endocrinol,查看原文。版权归原作者所有。

引用

  1. Jolliffe DA, Camargo CA, Sluyter JD, et al. Vitamin D supplementation to prevent acute respiratory infections: systematic review and meta-analysis of stratified aggregate data. Lancet Diabetes Endocrinol. 2025. PMID: 39993397. doi:10.1016/S2213-8587(24)00348-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。